PGx DNA Testing
Over 4 billion prescriptions are issued each year. However, not all drugs are effective for all people. In fact, response rates for many drugs are only between 50-75%. Adverse drug reactions (ADRs) account for up to 7% of all hospital admissions and up to 20% of re-admissions, according to estimates. ADRs are the fourth leading cause of death and are estimated to cost $136 billion annually. An estimated 10-20% of ADRs may be due to genetic factors.
Healthcare providers like you may use pharmacogenomic information to make better prescription decisions.
The PGx comprehensive test covers HUNDREDS OF THE MOST COMMONLY USED MEDICATIONS across psychiatry, oncology, pain, cardiology, and MANY OTHER DISEASE AREAS.
Why Test?
Patients have differences in DNA that impact drug metabolism which may increase their likelihood of an adverse drug reaction:
- Patients have differences in DNA that impact drug metabolism which may increase their likelihood of an adverse drug reaction.
- More than 85% of the population have detectable variations in their DNA that increase their risk for adverse drug reactions.
- Adverse drug reactions are the 4th leading cause of death nationwide with more than 8.6 million cases reported annually.
- The FDA highlights pharmacogenomics data for more than 130 prescription medications, indicating their strong support for testing.
Who To Test?
We advises pharmacogenomics testing for patients that meet one or more of the following conditions:
- Patients that experience less than optimal results from prescribed medications.
- Patients with a personal or family history of adverse drug reactions in response to certain medications.
- Polypharmacy patients; those taking multiple prescription medications for multiple chronic conditions.